Skip to main content
Premium Trial:

Request an Annual Quote

Nucleix Wins €2.5M EU Grant for Lung Cancer Diagnostic

NEW YORK (GenomeWeb) — Israeli molecular diagnostics firm Nucleix announced today that it has won a €2.5 million ($2.9 million) Horizon 2020 grant from the European Commission to continue development of its lung cancer screening test.

The test, called Lung EpiCheck, uses changes in DNA methylation patterns in blood samples for the early detection of lung cancer. It is based on the same technology as the firm's recently CE-marked Bladder EpiCheck urine test for bladder cancer monitoring.

With the new funding, Nucleix said it expects to move Lung EpiCheck into US and European clinical trials around the beginning of 2019.

The company, which won a €50,000 Horizon 2020 grant for its EpiCheck technology in 2016, is also developing cirrhosis and pan-cancer diagnostics.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.